• English
  • 简体中文
Login Register
Current Location: Home > Marketing Drugs(EU) Feedback Help
EMA Approvals
-
HMA Approvals
-

EMA:Drugs approved by European Medicines Agency through centralized Procedure. 

HMA:Drugs approved by EU members through Mutual Recognition Procedure.

For more information check in official website of members:

Drug label information in UK

Public Assessment Reports in UK

Marketed drugs in France

Marketed drugs in Italy

Marketed drugs in Switzerland

Marketed drugs in Sweden

Marketed drugs in Germany

Click here for more information

Brand name Nonproprietary Name Authorization date Marketing authorisation holder
Caelyx pegylated liposomal doxorubicin 1996-06-20 Baxter Holding B.V.
Myocet liposomal (previously Myocet) doxorubicin 2000-07-13 Teva B.V.
Celdoxome pegylated liposomal doxorubicin hydrochloride 2022-09-15 YES Pharmaceutical Development Services GmbH
Doxolipad doxorubicin 0000-00-00 TLC Biopharmaceuticals B.V.